BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/7/2020 2:46:34 PM | Browse: 1148 | Download: 2813
 |
Received |
|
2019-12-04 10:51 |
|
Peer-Review Started |
|
2019-12-04 10:51 |
|
First Decision by Editorial Office Director |
|
2020-01-16 22:36 |
|
Return for Revision |
|
2020-01-16 22:36 |
|
Revised |
|
2020-01-23 07:22 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-03-08 13:07 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-03-09 07:07 |
|
Articles in Press |
|
2020-03-09 07:07 |
|
Edit the Manuscript by Language Editor |
|
2020-03-23 02:13 |
|
Typeset the Manuscript |
|
2020-04-06 01:11 |
|
Publish the Manuscript Online |
|
2020-04-07 14:46 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Control Study |
| Article Title |
Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing Liang, Xiao-Feng Tian and Wei Yang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wei Yang, MD, Chief Physician, Department of Hepatopancreatobiliary Surgery, China-Japan Union Hospital of Jilin University, No. 126 Xiantai Avenue, Changchun 130000, Jilin Province, China. 18345893430@163.com |
| Key Words |
Long non-coding RNA Opa-interacting protein 5 antisense RNA 1; MicroRNA-137; Colon cancer; Drug resistance; Oxaliplatin; Biological behavior |
| Core Tip |
Long non-coding RNA (LncRNA) has drug resistance in various diseases, which has become a research hotspot, and it can participate in the regulation of various biological functions of cells. In this study, the expression and regulation mechanism of lncRNA Opa-interacting protein 5 antisense RNA 1 (OIP5-AS1) in colon cancer were explored, and it was found that lncRNA OIP5-AS1 was up-regulated in the cancer. Dual luciferase reporter gene and RNA-binding protein immunoprecipitation assays were carried out, and the relationship between microRNA-137 and OIP5-AS1 was found, which showed that OIP5-AS1 could mediate drug resistance of cells against oxaliplatin by regulating microRNA-137. |
| Publish Date |
2020-04-07 14:46 |
| Citation |
Liang J, Tian XF, Yang W. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137. World J Gastroenterol 2020; 26(13): 1474-1489 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i13/1474.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i13.1474 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
